Knowledge engineering for adverse drug event prevention: On the design and development of a uniform, contextualized and sustainable knowledge-based framework

Journal of Biomedical Informatics

Volumn 45, Issue 3, 2012, Pages 495-506

  Koutkias, Vassilis ^a   Kilintzis, Vassilis ^a   Stalidis, George ^a   Lazou, Katerina ^a   Niès, Julie ^b,c   Durand Texte, Ludovic ^d   McNair, Peter ^e   Beuscart, Régis ^c   Maglaveras, Nicos ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b MEDASYS   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d Vidal   (France)

^e Region Hovedstaden and Kennedy Center   (Denmark)

Author keywords

Adverse drug event (ADE) prevention; Clinical Decision Support System (CDSS); Contextualization; Knowledge engineering; Knowledge based framework; Patient safety

Indexed keywords

ADVERSE DRUG EVENT (ADE) PREVENTION; CLINICAL DECISION SUPPORT SYSTEMS; CONTEXTUALIZATION; KNOWLEDGE-BASED FRAMEWORK; PATIENT SAFETY;

COMPUTER ARCHITECTURE; DECISION SUPPORT SYSTEMS; KNOWLEDGE ENGINEERING;

KNOWLEDGE BASED SYSTEMS;

ADVERSE OUTCOME; ARTICLE; COMPUTER INTERFACE; CONCEPTUAL FRAMEWORK; DATA MINING; DECISION SUPPORT SYSTEM; DRUG SAFETY; HEALTH CARE SYSTEM; HUMAN; KNOWLEDGE BASE; LABORATORY TEST; PATIENT INFORMATION; PRIORITY JOURNAL;

DECISION SUPPORT SYSTEMS, CLINICAL; DRUG TOXICITY; HUMANS; KNOWLEDGE BASES;

EID: 84861883353     PISSN: 15320464     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbi.2012.01.007     Document Type: Article

References (56)

1. Schachter M. The epidemiology of medication errors: how many, how serious?. Br J Clin Pharmacol 2009, 67(6):621-623.
2. Institute Of Medicine Preventing medication errors 2007, The National Academic Press, Washington, DC.
3. Morimoto T., Gandhi T.K., Seger A.C., Hsieh T.C., Bates D.W. Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care 2004, 13(4):306-314.
4. Aronson J.K. Medication errors: definitions and classification. Br J Clin Pharmacol 2009, 67(6):599-604.
5. Nebeker J.R., Hurdle J.F., Hoffman J., Roth B., Weir C.R., Samore M.H. Developing a taxonomy for research in adverse drug events: potholes and signposts. J Am Med Inform Assoc 2002, 9(Nov-Dec suppl):S80-S85.
6. Amalberti R., Benhamou D., Auroy Y., Degos L. Adverse events in medicine: easy to count, complicated to understand, and complex to prevent. J Biomed Inform 2011, 44:390-394.
7. Bates D.W., et al. Detecting adverse events using Information Technology. J Am Med Inform Assoc 2003, 10(2):115-128.
8. Murff H.J., Patel V.L., Hripcsak G., Bates D.W. Detecting adverse events for patient safety research: a review of current methodologies. J Biomed Inform 2003, 36(1-2):131-143.
9. Jha A.K., et al. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc 1998, 5(3):305-314.
10. Brown J.S., et al. Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations. Pharmacoepidemiol Drug Saf 2009, 18(3):226-234.
11. Honigman B., Light P., Pulling R.M., Bates D.W. A computerised method for identifying incidents associated with adverse drug events in outpatients. Int J Med Inf 2001, 61(1):21-32.
12. Trifirò G., et al. Data mining on electronic health record databases for signal detection in pharmacovigilance. which events to monitor?. Pharmacoepidemiol Drug Saf 2009, 18(12):1176-1184.
13. Morimoto T., et al. Incidence of adverse drug events and medication errors in Japan: the JADE study. J Gen Intern Med 2011, 26(2):148-153.
14. Bousquet C., Henegar C., Lillo-Le Louët A., Degoulet P., Jaulent M.-C. Implementation of automated signal generation in pharmacovigilance using a knowledge-based approach. Int J Med Inform 2005, 74(7-8):563-571.
15. Estacio-Moreno A., Toussaint Y., Bousquet C. Mining for adverse drug events with formal concept analysis. Stud Health Technol Inform 2008, 136:803-808.
16. Ji Y., et al. A distributed adverse drug reaction detection system using intelligent agents with a fuzzy recognition-primed decision model. Int J Intell Syst 2007, 22(8):827-845.
17. Stephens S., Morales A., Quinlan M. Applying Semantic Web technologies to drug safety determination. IEEE Intell Syst 2006, 21(1):82-86.
18. Kuperman G.J., et al. Medication-related clinical decision support in computerized provider order entry systems: a review. J Am Med Inform Assoc 2007, 14(1):29-40.
19. Rommers M.K., et al. Development of a computerised alert system, ADEAS, to identify patients at risk for an adverse drug event. Qual Saf Health Care 2010, 19(6):e35.
20. Del Fiol G, Rocha BHSC, Nohama P. Modeling a decision support system to prevent adverse drug events. In: Proc of the 13th IEEE symp on CBMS; 2000. Available at: http://www.dx.doi.org/10.1109/CBMS.2000.856887.
21. Payne VL, Metzler DP. Hospital Care Watch (HCW): an ontology and rule-based intelligent patient management assistant. In: Proc of IEEE symp on CBMS; 2005. p. 479-84. Available at: http://www.dx.doi.org/10.1109/CBMS.2005.64.
22. Niès J., et al. Information contextualization in decision support modules for adverse drug event prevention. Stud Health Technol Inform 2011, 166:95-104.
23. Bernonville S., et al. Implementation of a taxonomy aiming to support the design of a contextualised clinical decision support system. Stud Health Technol Inform 2011, 166:74-83.
24. van der Sijs H., van Gelder T., Vulto A., Berg M., Aarts J. Understanding handling of drug safety alerts: a simulation study. Int J Med Inf 2010, 79(5):361-369.
25. Beuscart R., McNair P., Brender J. The PSIP Consortium, Patient safety through intelligent procedures in medication: the PSIP project. Stud Health Technol Inform 2009, 148:6-13.
26. Chazard E., Ficheur G., Bernonville S., Luyckx M., Beuscart R. Data mining to generate Adverse Drug Events detection rules. IEEE Trans Inf Technol Biomed 2011, 15(6):823-830.
27. Schreiber G. Knowledge engineering. Handbook of knowledge representation 2008, Elsevier. F. van Harmelen, V. Lifschitz, B. Porter (Eds.).
28. Studer R., Benjamins R., Fensel D. Knowledge engineering: principles and methods. Data Knowledge Eng 1998, 25(1-2):161-197.
29. Menzies T., van Harmelen F. Editorial: evaluating knowledge engineering techniques. Int J Human-Computer Stud 1999, 51(4):715-727.
30. Ligêza A. Logical foundations for rule-based systems. Studies in computational intelligence, vol. 11, 2nd ed. Berlin Heidelberg: Springer-Verlag; 2006.
31. Chazard E., et al. Detection of adverse drug events: proposal of a data model. Stud Health Technol Inform 2009, 148:63-74.
32. Chazard E., Ficheur G., Merlin B., Serrot E., Beuscart R. Adverse drug events prevention rules: multi-site evaluation of rules from various sources. Stud Health Technol Inform 2009, 148:102-111.
33. Abidi S.S.R., Cheah Y.-N., Curran J. A Knowledge creation info-structure to acquire and crystallize the tacit knowledge of health-care experts. IEEE Trans Inf Technol Biomed 2005, 9(2):193-204.
34. Marcilly R., et al. Medication related computerized decision support system (CDSS): make it a clinicians' partner!. Stud Health Technol Inform 2011, 166:84-94.
35. Koutkias V et al. Constructing clinical decision support systems for adverse drug event prevention: a knowledge-based approach. AMIA annu symp proc; 2010. p. 402-6.
36. de Clercq P., Kaiser K., Hasman A. Computer-interpretable guideline formalisms. Stud Health Technol Inform 2008, 139:22-43.
37. Peleg M., et al. Comparing computer-interpretable guideline models: a case-study approach. J Am Med Inform Assoc 2003, 10:52-68.
38. Wang D., et al. Representation primitives, process models and patient data in computer-interpretable clinical practice guidelines: a literature review of guideline representation models. Int J Med Inform 2002, 68(1-3):59-70.
39. Kumar A., Smith B., Pisanelli D.M., Gangemi A., Stefanelli M. Clinical guidelines as plans-an ontological theory. Methods Inf Med 2006, 45(2):204-210.
40. Sonnenberg F.A., Hagerty C.G. Computer-interpretable clinical practice guidelines. Where are we and where are we going?. IMIA Yearb Med Inform 2006, 145-158.
41. Peleg M. Guideline and workflow models. Clinical decision support: the road ahead 2007, Elsevier. R.A. Greenes (Ed.).
42. Musen M.A., Shahar Y., Shortliffe E.H. Clinical decision-support systems. Biomedical informatics: computer applications in health care and biomedicine 2006, Springer-Verlag. E.H. Shortliffe (Ed.).
43. de Clercq P.A., Blom J.A., Korsten H.H.M., Hasman A. Approaches for creating computer-interpretable guidelines that facilitate decision support. Artif Intell Med 2004, 31(1):1-27.
44. Latoszek-Berendsen A., Talmon J., de Clercq P., Hasman A. With good intentions. Int J Med Inf 2007, 76(S3):S440-S446.
45. van Oosterhout E.M.W., et al. Three-layer model for the design of a protocol support system. Int J Med Inf 2005, 74(2-4):101-110.
46. Grando A., Peleg M., Glasspool D. A goal-oriented framework for specifying clinical guidelines and handling medical errors. J Biomed Inform 2010, 43(2):287-299.
47. Seyfang A., Kaiser K., Miksch S. Modelling clinical guidelines and protocols for the prevention of risks against patient safety. Stud Health Technol Inform 2009, 150:633-637.
48. HL7/ANSI V3. GELLO: A common expression language, release 2; May 2010.
49. de Clercq P.A., Hasman A., Blom J.A., Korsten H.H.M. Design and implementation of a framework to support the development of clinical guidelines. Int J Med Inform 2001, 64(2-3):285-318.
50. The Protégé ontology editor and knowledge acquisition system. http://protege.stanford.edu/.
51. Drools - JBoss community. http://www.jboss.org/drools/.
52. Sordo M, Ogunyemi O, Boxwala AA, Greenes RA. Software specifications for GELLO: an object-oriented query and expression language for clinical decision support. Decision systems group, Brigham & Women's Hospital, Harvard Medical, School, Boston, MA, DSG-TR-2003-02; 2003.
53. Ammenwerth E., Hackl W.O., Massari P., Darmoni S. Validation of completeness, correctness, relevance and understandability of the PSIP CDSS for medication safety. Stud Health Technol Inform 2011, 166:254-259.
54. Bernonville S., Niès J., Gliese Pedersen H., Guillot B., Maazi M., Berg A.-L., et al. Three different cases of exploiting decision support services for adverse drug event prevention. Stud Health Technol Inform 2011, 166:180-188.
55. Adlassnig K.-P., Combi C., Das A.K., Keravnou E.T., Pozzi G. Temporal representation and reasoning in medicine: research directions and challenges. Artif Intell Med 2006, 38(2):101-113.
56. Wang HH et al. Frames and OWL side by side. In: Proc of the 9th int Protégé conf. Stanford University, California, USA; July 23-26, 2006.